arginine has been researched along with Chronic Liver Failure in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dragičević, M; Košuta, I; Kruezi, E; Lovrenčić, MV; Mrzljak, A | 1 |
| Andreola, F; Davies, N; De Chiara, F; Garcia-Martinez, R; Habtesion, A; Jalan, R; Jover, M; Macnaughtan, J; Mehta, G; Mookerjee, RP; Oria, M; Poulton, K; Soeda, J | 1 |
| Chen, CC; Hsieh, CS; Huang, LT; Sheen, JM; Tain, YL; Wang, JY | 1 |
| Gomes Martins, E; Santos Silva, E; Saudubray, JM; Vilarinho, L; Vilarinho, S | 1 |
| Rondina, MT; Varedi, A; Walker, A; Yarbrough, PM | 1 |
5 other study(ies) available for arginine and Chronic Liver Failure
| Article | Year |
|---|---|
Association of Asymmetric Dimethylarginine and Nitric Oxide with Cardiovascular Risk in Patients with End-Stage Liver Disease.
Topics: Adult; Arginine; Cardiovascular Diseases; End Stage Liver Disease; Heart Disease Risk Factors; Humans; Nitric Oxide; Risk Factors; Severity of Illness Index | 2020 |
Immunomodulatory and antioxidant function of albumin stabilises the endothelium and improves survival in a rodent model of chronic liver failure.
Topics: Albumins; Animals; Arginine; Disease Models, Animal; End Stage Liver Disease; Endothelium, Vascular; Hemodynamics; Humans; Inflammation; Nitric Oxide Synthase; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; von Willebrand Factor | 2015 |
Bile duct ligation in developing rats: temporal progression of liver, kidney, and brain damage.
Topics: Animals; Arginine; Bile Ducts; Brain; Brain Diseases; Cholestasis; Disease Progression; End Stage Liver Disease; Kidney; Kidney Diseases; Laparotomy; Ligation; Lipocalins; Liver; Male; Oxidative Stress; Rats; Rats, Sprague-Dawley; Time Factors | 2010 |
Neonatal cholestasis: an uncommon presentation of hyperargininemia.
Topics: Amino Acids, Essential; Arginase; Arginine; Biomarkers; Child; Child Development; Child, Preschool; Cholestasis; Diet, Protein-Restricted; Disease Progression; End Stage Liver Disease; Female; Genetic Predisposition to Disease; Humans; Hyperargininemia; Hypertension, Portal; Infant; Infant, Newborn; Liver Cirrhosis, Biliary; Liver Transplantation; Neonatal Screening; Phenotype; Treatment Outcome | 2010 |
Argatroban dose reductions for suspected heparin-induced thrombocytopenia complicated by child-pugh class C liver disease.
Topics: Anticoagulants; Antithrombins; Arginine; End Stage Liver Disease; Heparin; Humans; Kidney Failure, Chronic; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Pipecolic Acids; Platelet Aggregation Inhibitors; Sulfonamides; Thrombocytopenia | 2012 |